SCHEMBL27252002

SCHEMBL27252002

CCn1ccc2cccnc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.48
HTR2C P28335 1/20 0.48
HTR2B P41595 1/20 0.48
HTR1A P08908 4/20 0.45
DRD2 P14416 4/20 0.45
KDM4E B2RXH2 3/20 0.44
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
LMNA P02545 2/20 0.44
CYP3A4 P08684 2/20 0.44
MMP2 P08253 2/20 0.44
TSHR P16473 2/20 0.44
GMNN O75496 1/20 0.44
TP53 P04637 1/20 0.44
HSP90AA1 P07900 1/20 0.44
CYP2D6 P10635 1/20 0.44
MMP9 P14780 1/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 1/20 0.44
MMP8 P22894 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4064145 0.80 MAPK14 (0.47) HTR2AHTR1ADRD2EIF4EBP1PDE4A
SCHEMBL20975437 0.79 KDM4E (0.52) KDM4ELMNATSHRTP53HTT
SCHEMBL15135382 0.78 METAP2 (0.42) HTR2AHTR2CHTR2BKDM4EMAPT
SCHEMBL20975432 0.77 KDM4E (0.48) HTR2AHTR2CHTR2BKDM4EMAPT
SCHEMBL2543931 0.75 MTNR1A (0.55) HTR2AHTR2CHTR2BMTNR1ACYP2C19
SCHEMBL23758074 0.75 HTR2A (0.44) HTR2AHTR2CHTR2BHTR1ADRD2
SCHEMBL1666075 0.75 NR3C1 (0.44) HTR2AHTR2CHTR2BKDM4EMAPT
SCHEMBL27277552 0.74 LMNA (0.48) HTR2AHTR2CHTR2BKDM4EMAPT
SCHEMBL21931157 0.73 MAPT (0.44) HTR2AHTR2CHTR2BKDM4EMAPT
SCHEMBL22214046 0.73 HTR2A (0.44) HTR2AHTR2CHTR2BKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199604-A1 SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199604-A1 SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS MAPT, HTT, PSEN1 HTR2A 4191/4885HTR2C 4449/4885HTR2B 3833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.